|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.050 USD | -1.94% |
|
-6.90% | -25.93% |
| 01-22 | Alert wrongly tagged to Bolt Biotherapeutics Inc withdrawn | RE |
| 01-15 | Bolt appoints Olta Andoni as SVP of legal and people to support platform expansion across checkout, identity, and payments | RE |
Company Valuation: Bolt Biotherapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 182.7 | 48.96 | 42.52 | 20.48 | 7.774 | 7.774 | - |
| Change | - | -73.2% | -13.15% | -51.84% | -62.04% | 0% | - |
| Enterprise Value (EV) | -3.524 | -97.32 | -39.45 | 20.48 | 7.774 | 7.774 | 7.774 |
| Change | - | -2,661.37% | 59.46% | 151.92% | -62.04% | 0% | 0% |
| P/E ratio | -1.65x | -0.55x | -0.61x | -0.32x | -0.19x | -0.22x | -0.26x |
| PBR | 0.73x | 0.29x | 0.38x | - | - | - | - |
| PEG | - | 0x | 0x | 0.03x | 0x | 0x | 0x |
| Capitalization / Revenue | 145x | 8.55x | 5.4x | 2.66x | 1.33x | 1.4x | 0.64x |
| EV / Revenue | -0x | -0x | -0x | 0x | 1.33x | 1.4x | 0.64x |
| EV / EBITDA | - | - | - | - | - | - | - |
| EV / EBIT | 0x | 0x | 0x | -0x | -0.18x | -0.16x | -0.14x |
| EV / FCF | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | -59.4 | -47.2 | -36.6 | -33 | -20.95 | -18.26 | -15.33 |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | 1.26 | 5.729 | 7.876 | 7.69 | 5.865 | 5.541 | 12.19 |
| EBITDA | -83.1 | -79.08 | -65.12 | - | - | - | - |
| EBIT 1 | -92.79 | -90.32 | -76.2 | -73.05 | -42.55 | -49.3 | -57.27 |
| Net income 1 | -98.59 | -88.1 | -69.2 | -63.12 | -38.56 | -41.82 | -36.91 |
| Net Debt | -186.2 | -146.3 | -81.97 | - | - | - | - |
| Reference price 2 | 98.000 | 26.000 | 22.400 | 10.702 | 4.050 | 4.050 | 4.050 |
| Nbr of stocks (in thousands) | 1,864 | 1,883 | 1,898 | 1,914 | 1,919 | 1,919 | - |
| Announcement Date | 30/03/22 | 29/03/23 | 21/03/24 | 24/03/25 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.2x | - | - | - | 7.77M | |
| 42.74x | 10x | 36.07x | 0.03% | 43.46B | |
| 15.94x | 5.69x | 12.52x | 1.88% | 39.86B | |
| -51.84x | 17.45x | -57.65x | -.--% | 30.07B | |
| -17.5x | 4.48x | -8.41x | -.--% | 21.62B | |
| 27.64x | 5.7x | 15.82x | -.--% | 18.57B | |
| 22.04x | 4.19x | 13.68x | -.--% | 16.5B | |
| -329.09x | 27.33x | 1504.74x | -.--% | 13.08B | |
| -14.2x | 6349.59x | -18.15x | -.--% | 11.99B | |
| -169.65x | 41.3x | -164.02x | -.--% | 11.56B | |
| Average | -47.41x | 718.41x | 148.29x | 0.21% | 20.67B | |
| Weighted average by Cap. | -24.20x | 379.33x | 88.20x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- BOLT Stock
- Valuation Bolt Biotherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition